Cleared Traditional

Self-adhesive Electrode (K222453) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222453 · Guangdong Comytens Medical Technology Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2022
Decision
81d
Days
Class 2
Risk

K222453 is an FDA 510(k) clearance for the Self-adhesive Electrode. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Guangdong Comytens Medical Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on November 4, 2022 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Guangdong Comytens Medical Technology Co., Ltd. devices

Submission Details

510(k) Number K222453 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2022
Decision Date November 04, 2022
Days to Decision 81 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 148d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 97
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K222453.
Alpha Control Liner System (ACLS)
K223738 · Coapt · Jan 2023
EZ-STIK Electrodes
K223775 · South Dakota Partners · Jan 2023
ControlSeal Electrode (ELSB)
K223605 · Coapt · Dec 2022
Dexus Prosthetics System (Model: MSL1, MSR1)
K220002 · Zhejiang Qiangnao Technology Co.,Ltd · Sep 2022
Disposable EEG cable
K213884 · Shenzhen Changke Connect Electronics Co., Ltd. · May 2022
Self-adhesive Electrode
K213879 · Bozhou Rongjian Medical Appliance Co., Ltd. · Jan 2022